Lugano, Switzerland, 16 November 2026 – Coinciding with the opening of the second edition of the ESMO AI & Digital Oncology Congress (AI&DO), ESMO has announced the launch of
ESMO Artificial Intelligence and Oncology, a new peer-reviewed journal focused on the application of artificial intelligence across cancer research and care.
Dedicated to publishing data science and educational content on the transformation of oncology through AI, the journal will feature original research, reviews, editorials, perspectives, correspondence and news. Coverage will span a broad range of topics, including pathology, molecular profiling, imaging, clinical decision support, drug development, healthcare workflows, regulation, education and health economics.
ESMO Artificial Intelligence and Oncology will provide a platform for the evaluation, validation and implementation of AI applications in cancer care, while promoting methodological rigour, transparency and multidisciplinary collaboration.
The journal's Editor-in-Chief, Prof. Dr. med. Jakob Nikolas Kather, MSc, said:
"Artificial intelligence is becoming a core technology in oncology. ESMO has an important role to play in providing a trusted forum for the dissemination of research and the evaluation of the benefits and potential risks associated with AI systems in clinical cancer care."
Currently Hopp Foundation Professor of Artificial Intelligence in Medicine and Founding Director of the Institute for Medical AI at Heidelberg University Hospital, Kather has outlined a vision for the journal centred on clinically relevant research, prospective validation studies of AI tools, alongside educational content designed to support the oncology community in understanding and applying AI in practice.
The launch of the journal further expands ESMO's activities in the field of artificial intelligence, which include scientific and educational initiatives, policy work and the
annual AI & Digital Oncology Congress. Together, these efforts reflect the Society's commitment to supporting the responsible development and use of AI for the ultimate benefit of people affected by cancer.
With continuous online publication and a rigorous peer-review process,
ESMO Artificial Intelligence and Oncology aims to accelerate the dissemination of evidence, practical guidance and educational resources that can support the integration of AI into cancer research and patient care.
-END-